Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
alopecia
Fierce Pharma
Veradermics locks in $256M IPO, shares spike
With an oversubscribed trading debut now in the books, Veradermics is well coiffed to tap into the growing opportunity for pattern hair loss drugs.
Fraiser Kansteiner
Feb 5, 2026 10:01am
Nektar claims ph. 2 alopecia success after excluding 4 patients
Dec 16, 2025 5:05pm
Fierce Pharma
Veradermics grows hair loss med hopes on $150M funding wave
Oct 16, 2025 7:30am
Pelage locks in $120M series B for hair growth program
Oct 15, 2025 7:00am
HCW Biologics clings on with $5M lifeline to fund alopecia trial
May 16, 2025 7:00am
Q32 Bio sticks with bempikibart but lets go of staff
Feb 11, 2025 4:47am
